These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 25802446

  • 1. Aberrant expression of Fcγ-receptors and Toll like receptor CD180 on monocytes from patients with chronic lymphocytic leukaemia.
    Tsertsvadze TSh, Mitskevich NG, Ghirdaladze DM, Porakishvili NZ.
    Georgian Med News; 2015 Feb; (239):35-8. PubMed ID: 25802446
    [Abstract] [Full Text] [Related]

  • 2. PHAGOCYTOSIS AND EXPRESSION OF FCg-RECEPTORS AND CD180 ON MONOCYTES IN CHRONIC LYMPHOCYTIC LEUKEMIA.
    Tsertsvadze T, Mitskevich N, Bilanishvili A, Girdaladze D, Porakishvili N.
    Georgian Med News; 2017 Sep; (270):88-93. PubMed ID: 28972490
    [Abstract] [Full Text] [Related]

  • 3. Correlation of the expression of CD32 and CD180 receptors on CLL cells and MEC1 cell line.
    Tsertsvadze T, Mitskevich N, Ghirdaladze D, Porakishvili N.
    Georgian Med News; 2015 Mar; (240):56-9. PubMed ID: 25879560
    [Abstract] [Full Text] [Related]

  • 4. Circulating classical CD14++CD16- monocytes predict shorter time to initial treatment in chronic lymphocytic leukemia patients: Differential effects of immune chemotherapy on monocyte-related membrane and soluble forms of CD163.
    Lapuc I, Bolkun L, Eljaszewicz A, Rusak M, Luksza E, Singh P, Miklasz P, Piszcz J, Ptaszynska-Kopczynska K, Jasiewicz M, Kaminski K, Dabrowska M, Bodzenta-Lukaszyk A, Kloczko J, Moniuszko M.
    Oncol Rep; 2015 Sep; 34(3):1269-78. PubMed ID: 26135617
    [Abstract] [Full Text] [Related]

  • 5. Changed phagocytic activity and pattern of Fcγ and complement receptors on blood monocytes in sarcoidosis.
    Dubaniewicz A, Typiak M, Wybieralska M, Szadurska M, Nowakowski S, Staniewicz-Panasik A, Rogoza K, Sternau A, Deeg P, Trzonkowski P.
    Hum Immunol; 2012 Aug; 73(8):788-94. PubMed ID: 22609476
    [Abstract] [Full Text] [Related]

  • 6. ATTACHMENT OF CHRONIC LYMPHOCYTIC LEUKAEMIA CELLS BY AUTOLOGOUS POLYMORPHONUCLEAR NEUTROPHILS MEDIATED BY BISPECIFIC ANTI-CD19/CD64 ANTIBODY.
    Tsertsvadze T, Mitskevich N, Datikashvili-David I, Ghirdaladze D, Porakishvili N.
    Georgian Med News; 2020 Nov; (308):118-123. PubMed ID: 33395652
    [Abstract] [Full Text] [Related]

  • 7. Monoclonal antibodies capable of discriminating the human inhibitory Fcgamma-receptor IIB (CD32B) from the activating Fcgamma-receptor IIA (CD32A): biochemical, biological and functional characterization.
    Veri MC, Gorlatov S, Li H, Burke S, Johnson S, Stavenhagen J, Stein KE, Bonvini E, Koenig S.
    Immunology; 2007 Jul; 121(3):392-404. PubMed ID: 17386079
    [Abstract] [Full Text] [Related]

  • 8. Fcγ receptor polymorphisms and clinical efficacy of rituximab in non-Hodgkin lymphoma and chronic lymphocytic leukemia.
    Zhuang Y, Xu W, Shen Y, Li J.
    Clin Lymphoma Myeloma Leuk; 2010 Oct; 10(5):347-52. PubMed ID: 21030347
    [Abstract] [Full Text] [Related]

  • 9. MD-1 downregulation is associated with reduced cell surface CD180 expression in CLL.
    Edwards K, Manoussaka M, Sayed U, Tsertsvadze T, Deyn L, Nathwani A, Gribben JG, Krysov S, Volpi EV, Lydyard PM, Porakishvili N.
    Leuk Res; 2024 Aug; 143():107540. PubMed ID: 38897026
    [Abstract] [Full Text] [Related]

  • 10. Different expression of CD180, CD284 and CD14 receptors on the CD19+ subpopulation of normal and B-CLL lymphocytes.
    Antosz H, Sajewicz J, Marzec-Kotarska B, Kocki J, Dmoszyńska A.
    Folia Histochem Cytobiol; 2009 Aug; 47(4):593-8. PubMed ID: 20430725
    [Abstract] [Full Text] [Related]

  • 11. The monocytic population in chronic lymphocytic leukemia shows altered composition and deregulation of genes involved in phagocytosis and inflammation.
    Maffei R, Bulgarelli J, Fiorcari S, Bertoncelli L, Martinelli S, Guarnotta C, Castelli I, Deaglio S, Debbia G, De Biasi S, Bonacorsi G, Zucchini P, Narni F, Tripodo C, Luppi M, Cossarizza A, Marasca R.
    Haematologica; 2013 Jul; 98(7):1115-23. PubMed ID: 23349302
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Human plasma contains a soluble form of CD86 which is present at elevated levels in some leukaemia patients.
    Hock BD, Patton WN, Budhia S, Mannari D, Roberts P, McKenzie JL.
    Leukemia; 2002 May; 16(5):865-73. PubMed ID: 11986949
    [Abstract] [Full Text] [Related]

  • 14. The interplay of CD150 and CD180 receptor pathways contribute to the pathobiology of chronic lymphocytic leukemia B cells by selective inhibition of Akt and MAPK signaling.
    Gordiienko I, Shlapatska L, Kholodniuk V, Sklyarenko L, Gluzman DF, Clark EA, Sidorenko SP.
    PLoS One; 2017 May; 12(10):e0185940. PubMed ID: 28982149
    [Abstract] [Full Text] [Related]

  • 15. CD180 functions in activation, survival and cycling of B chronic lymphocytic leukaemia cells.
    Porakishvili N, Memon A, Vispute K, Kulikova N, Clark EA, Rai KR, Nathwani A, Damle RN, Chiorazzi N, Lydyard PM.
    Br J Haematol; 2011 May; 153(4):486-98. PubMed ID: 21443749
    [Abstract] [Full Text] [Related]

  • 16. Type I (CD64) and type II (CD32) Fc gamma receptor-mediated phagocytosis by human blood dendritic cells.
    Fanger NA, Wardwell K, Shen L, Tedder TF, Guyre PM.
    J Immunol; 1996 Jul 15; 157(2):541-8. PubMed ID: 8752900
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Differential enhancement of dengue virus immune complex infectivity mediated by signaling-competent and signaling-incompetent human Fcgamma RIA (CD64) or FcgammaRIIA (CD32).
    Rodrigo WW, Jin X, Blackley SD, Rose RC, Schlesinger JJ.
    J Virol; 2006 Oct 15; 80(20):10128-38. PubMed ID: 17005690
    [Abstract] [Full Text] [Related]

  • 19. Expression of Fcgamma and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis.
    Hepburn AL, Mason JC, Davies KA.
    Rheumatology (Oxford); 2004 May 15; 43(5):547-54. PubMed ID: 14747618
    [Abstract] [Full Text] [Related]

  • 20. Chronic lymphocytic leukaemia cells are efficiently killed by an anti-CD20 monoclonal antibody selected for improved engagement of FcgammaRIIIA/CD16.
    de Romeuf C, Dutertre CA, Le Garff-Tavernier M, Fournier N, Gaucher C, Glacet A, Jorieux S, Bihoreau N, Behrens CK, Béliard R, Vieillard V, Cazin B, Bourel D, Prost JF, Teillaud JL, Merle-Béral H.
    Br J Haematol; 2008 Mar 15; 140(6):635-43. PubMed ID: 18302712
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.